Compare Humana Inc (HUM) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Procter & Gamble Co — how do they compare? Humana Inc trades at $406.29 (market cap $47.81B), while Procter & Gamble Co trades at $147.66 (market cap $347.26B). The key difference: Procter & Gamble Co is far larger — about 7.3× Humana Inc's market cap, and Procter & Gamble Co pays the higher dividend (2.92%). Which is the better fit depends on your goals.
| HUM | PG | |
|---|---|---|
Market Cap | $47.81B | $347.26B |
Sector | Health | Consumer Staples |
52-Week High | $409.42 | $167.18 |
52-Week Low | $163.67 | $138.10 |
Enterprise Value | $56.85B | $372.74B |
Dividend Yield | 0.89% | 2.92% |
Volume | — | 6,423,436 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Procter & Gamble (PG) trades at $147.47, down 1.66% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $161.71. The company reported revenue of $84.28 billion in 2025, with net income of $15.97 billion and a net margin of 18.95%. Recent quarterly earnings have consistently beaten expectations, and the company maintains a strong dividend history, with recent payouts of $1.09 per share.
PG offers stability with consistent earnings and dividend growth, but faces risks from premium valuations and modest revenue growth. The stock's upside is supported by operational efficiency gains and strong cash flow, though investor sentiment is mixed due to high P/E and P/S ratios relative to peers. Macroeconomic pressures and competitive dynamics remain key watchpoints for sustained performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
